The last decade has witnessed a seismic shift in biotechnology with the advent of GLP-1 weight-loss drugs, heralded as a monumental breakthrough. However, for a growing number of clinical psychologists, these powerful medications represent a far more troubling development: a potential accelerant for the escalating crisis of eating disorders. A recent, deeply concerning report paints a stark picture, revealing a staggering 71% surge in the global incidence of anorexia nervosa and bulimia nervosa between 1990 and 2023. This alarming trend means that by 2023, an estimated 18.1 million individuals worldwide were living with one of these two debilitating conditions.

The gravity of this situation is amplified by the understanding that these figures likely represent a significant undercount. The current estimates meticulously detail only anorexia and bulimia, omitting a spectrum of other serious eating disorders. Experts in the field are increasingly witnessing a disturbing correlation: the burgeoning popularity of GLP-1 weight-loss drugs appears to be exacerbating these pre-existing mental health challenges. Cheri Levinson, a clinical psychologist at the University of Louisville in Kentucky with nearly two decades of specialization in eating disorders, articulates the severity of the current climate. She reports observing an unprecedented rise in patients presenting with more severe symptoms than at any other point in her extensive career. A critical factor contributing to this crisis, she notes, is the observed misuse of GLP-1 medications among these vulnerable individuals. "This is the worst I’ve seen things," Levinson states with palpable concern, underscoring the urgent need for attention and intervention.

Eating disorders, by definition, are complex mental health conditions where an individual’s relationship with food and eating behaviors profoundly impacts their physical and psychological well-being. They encompass a range of disorders, including anorexia nervosa, characterized by an intense fear of gaining weight and a distorted body image; bulimia nervosa, marked by cycles of binge eating followed by compensatory behaviors such as purging; and binge eating disorder, defined by recurrent episodes of consuming large quantities of food in a short period. While the precise etiology of eating disorders remains multifaceted, research suggests a confluence of factors. A genetic predisposition may render some individuals more vulnerable, but external triggers are often instrumental in initiating the disorder’s onset. These triggers can include significant stress, pervasive societal pressure to conform to unrealistic thinness ideals, or, as Levinson highlights, the very act of restricting food intake, which can paradoxically activate disordered eating patterns.

The pervasive societal pressure to achieve a slender physique, coupled with the existence of eating disorders, was already a significant concern in the 1990s, a period often recalled for its "heroin chic" aesthetic. To quantify the evolution of this crisis over the subsequent decades, a comprehensive global study was undertaken. Ruhai Bai, from the Children’s Hospital of Nanjing Medical University in China, and his esteemed colleagues embarked on a meticulous data-gathering mission, compiling information from numerous studies and surveys conducted across diverse populations worldwide. Employing sophisticated statistical modeling techniques, the research team was able to bridge any data gaps and provide robust estimates.

This monumental research effort enabled the estimation of the annual incidence of anorexia nervosa and bulimia nervosa across 204 countries and territories, spanning the period from 1990 to 2023. Crucially, the study also sought to quantify the global health burden imposed by these disorders by calculating their disability-adjusted life years (DALYs). A DALY serves as a critical metric, representing one year of healthy life lost due to illness, disability, or premature death.

The findings, recently published in the prestigious journal JAMA Psychiatry, are profoundly unsettling. Between 1990 and 2023, the study revealed a dramatic 71% increase in the incidence of anorexia nervosa and bulimia nervosa. The impact on global health is equally stark. In 2023 alone, these two disorders collectively "cost the world the equivalent of about 3.83 million years of healthy life," according to Bai.

The projections for the future are equally sobering. Bai and his team anticipate a continued upward trajectory in these figures. While an estimated 18.1 million individuals lived with anorexia or bulimia in 2023, their predictions suggest that by 2050, these conditions could affect as many as 21.8 million people.

The picture becomes even more alarming when considering that anorexia and bulimia represent less than half of all recognized eating disorders. Levinson, who was not involved in Bai’s study, posits that the true scale of the problem is likely "probably three times the rate that they’re reporting," indicating a far more pervasive and widespread crisis than even the current alarming statistics suggest.

While Bai and his colleagues did not delve into the specific causative factors behind this alarming rise – though Bai notes that population growth alone cannot account for the dramatic increase – the contributing elements have been a subject of extensive discussion and research. One significant factor identified is the pervasive influence of social media. Cynthia Bulik, a clinical psychologist at the University of North Carolina and a leading expert in the field who was not involved in the new study, explains how social media platforms can act as potent catalysts for eating disorders. "Social media comparisons, influencers, challenges, diet trends can all be precipitating… events for an eating disorder," Bulik states. She observes that the period between 1990 and 2023 has witnessed a clear "upsurge of those types of environmental exposures."

The curated and often digitally altered images presented by influencers, who may have undergone cosmetic surgery or adhered to extreme dieting regimens, frequently promote "thinspiration" or "fitspiration" content. For individuals with a predisposition to or existing eating disorders, social media algorithms appear to amplify this exposure, feeding them an overwhelming amount of content focused on dieting, excessive exercise, and idealized body types. A few years ago, researchers at the University of Melbourne investigated this phenomenon, discovering that TikTok algorithms delivered a staggering 4343% more "toxic eating disorder videos" to users with diagnosed eating disorders compared to those without. Many of these users were reportedly exposed to over a thousand problematic videos per month. Bulik aptly describes social media as "quicksand" for individuals grappling with or at risk of developing eating disorders.

The COVID-19 pandemic and the subsequent social isolation imposed by lockdowns have also been identified as significant contributors to the rise in eating disorders. Research conducted in 2021 indicated a doubling of hospitalizations for eating disorders in the United States between 2018 and 2020, a stark testament to the pandemic’s impact.

While comprehensive data on eating disorder trends since 2023 is still emerging, anecdotal evidence suggests a worsening situation. Levinson reports observing an increase in both the prevalence and severity of eating disorders, alongside an alarming trend of earlier ages of onset. "We’re seeing eight- and nine-year-olds with eating disorders," she states with grave concern. "From what I’m hearing and seeing, I am not going to be surprised if that number isn’t at least doubling again," she adds, forecasting a potential further dramatic escalation of the crisis.

Levinson’s particular concern is directed towards the burgeoning influence of GLP-1 weight-loss drugs. These medications have experienced an explosive surge in popularity in recent years. A Gallup survey earlier this year indicated that a substantial 15% of Americans have utilized these drugs for weight loss. The accessibility of these drugs is also increasing, with pharmaceutical companies developing more convenient and effective formulations, and individuals obtaining them through compounding pharmacies or illicit online sources.

In a small but significant study published earlier this year, Levinson and her colleagues found that a concerning 30% of individuals diagnosed with eating disorders had used GLP-1 drugs. While the drugs may offer some therapeutic benefits for a subset of these individuals, the study revealed that approximately 10% appeared to have misused the medications. Levinson believes this figure is likely an underestimate, given the clandestine nature of such misuse.

Levinson and her team have documented cases of children developing eating disorders after being prescribed GLP-1s for legitimate medical reasons. Furthermore, they have witnessed children as young as 11 obtaining these drugs through platforms like TikTok. "We’re very concerned that GLPs will lead to even faster and more extreme weight loss in people with anorexia nervosa, and that patients will come to us in even more advanced stages of illness that become difficult to reverse," warns Bulik.

Both Bulik and Levinson are actively continuing their research into the complex interplay between GLP-1 drugs and eating disorders. In the interim, they are issuing a fervent plea to medical professionals to thoroughly consider the potential risks these medications pose to individuals with pre-existing eating disorders. Bulik was a contributor to a set of research and clinical guidelines, published earlier this month, that strongly recommends that physicians conduct thorough screening for eating disorders prior to prescribing GLP-1s. The guidelines also emphasize the critical importance of enhanced patient education and more rigorous monitoring of individuals undergoing treatment with these potent medications.

For those seeking information and support regarding eating disorders, the National Eating Disorders Association offers a valuable resource.